SecBot SecBot
144 ·Filed Nov 9, 2026

RCKT

ROCKET PHARMACEUTICALS, INC.
NEUTRAL
Impact 2/10
Horizonimmediate Processed7d 11h ago SEC0001959173-26-007867
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

The sale is small relative to market cap and appears to be a tax-withholding sale tied to equity vesting, not a discretionary insider reduction. Monitor for any subsequent Form 4 filings to confirm execution and for any larger insider sales that could signal a change in sentiment.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5
Entry
$2.53
T+0 close · Nov 9, 2026 · via day close
Latest settled
−14.62%
T+5 · $2.16
Vs SPY
−12.93%
α at T+5
Next horizon
T+20
in 21d
  1. T+0 · Nov 9 $2.53entry
  2. T+1 · 7d ago −3.16%α −2.79% · $2.45
  3. T+5 · 20h ago −14.62%α −12.93% · $2.16
  4. T+20 · in 21d Pending
  5. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Sarbani Chaudhuri, an officer of Rocket Pharmaceuticals, filed a Form 144 notice of intent to sell 4,872 shares of common stock with an approximate market value of $11,335. The shares were acquired via restricted stock vesting on November 5, 2026. The filing notes that the sale includes shares needed to cover a tax obligation from the vesting of an equity award, indicating this is a routine tax-related sale rather than a discretionary portfolio reduction.

Key Facts

  • Officer Sarbani Chaudhuri filed Form 144 to sell 4,872 shares of common stock
  • Estimated aggregate market value of shares: $11,335.20
  • Shares acquired via restricted stock vesting on November 5, 2026
  • Sale includes shares to cover tax obligation from vested equity award
  • Sale intended to be executed on or about November 9, 2026 on Nasdaq
  • Company market cap is approximately $267M; proposed sale represents ~0.004% of market cap

Financial Impact

Proposed sale of 4,872 shares valued at approximately $11,335, representing about 0.004% of the company's $267M market cap

dilution

Risk Factors

  • Form 144 is an intent to sell; the actual sale may not occur
  • No information on the officer's total holdings to assess proportionality of this sale

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
60% bullish (20 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001959173-26-007867
Document: 0001959173-26-007867-index.html0001959173-26-007867
Document: 0001959173-26-007867.txt0001959173-26-007867

Track record

21 reports on RCKT

Performance horizon

5 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +42.18% at T+20 after the Jun 12, 2026 report. 6 of 6 went positive at some point.

Filters
  1. Nov 13, 20263d ago 144 Neutral 2/10 Entry $2.45 Now $2.16 −11.84% settles Dec 15
  2. Nov 13, 20263d ago 144 Neutral 2/10 Entry $2.30 Now $2.16 −6.09% settles Dec 14
  3. Nov 12, 20264d ago Insider Cluster Neutral 3/10 Entry $2.30 Now $2.16 −6.09% settles Dec 14
  4. Nov 12, 20264d ago 8-K Neutral 5/10 Entry $2.30 Now $2.16 −6.09% settles Dec 14
  5. Nov 9, 20267d ago 144 Neutral 2/10 Entry $2.53 Now $2.16 −14.62% settles Dec 8
  6. Nov 9, 20267d ago 144 Neutral 2/10 Viewing Entry $2.53 Now $2.16 −14.62% settles Dec 8
  7. Nov 5, 202611d ago 144 Neutral 2/10 Entry $2.44 Now $2.16 −11.29% settles Dec 4
  8. Oct 30, 202617d ago SC 13G/A Neutral 2/10 Entry $2.44 Now $2.16 −11.48% settles Nov 30
  9. Oct 6, 20265w ago 8-K Bullish 7/10 Entry $2.54 to $2.57 Now $2.16 −14.79% ▲ +1.38% +2.62% vs SPY
  10. Sep 15, 20268w ago 8-K Bullish 7/10 Entry $3.41 to $2.30 Now $2.16 −36.66% ▼ −32.55% −35.27% vs SPY
Showing 10 of 21

US Market Status

Market Closed · Opens in 6h 41m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 9, 2026